Compare AOMR & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOMR | STXS |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.7M | 201.6M |
| IPO Year | 2019 | 2004 |
| Metric | AOMR | STXS |
|---|---|---|
| Price | $8.49 | $2.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $11.31 | $4.00 |
| AVG Volume (30 Days) | 91.4K | ★ 405.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 14.88% | N/A |
| EPS Growth | ★ 53.85 | N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | N/A | $24.21 |
| Revenue Next Year | $0.83 | $29.83 |
| P/E Ratio | $4.78 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.36 | $1.54 |
| 52 Week High | $10.21 | $3.59 |
| Indicator | AOMR | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 43.50 |
| Support Level | $8.18 | $2.06 |
| Resistance Level | $8.91 | $2.49 |
| Average True Range (ATR) | 0.23 | 0.12 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 31.00 | 28.77 |
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.